Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.